Τόμος 22 (2008) – Τεύχος 2 – Άρθρο 71 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 22 (2008) – Issue 2 – Article 71 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Administration of antiplatelet agents in cardiovascular disorders: results from a clinical study
Authors Μ. Mironidou-Tzouveleki1, Ch. Dokos1, M. Andronoglou1, P. Papadimouli2 and K. Kalousis1

1A’ Laboratory of Pharmacology, Medical School, Aristotelian University, Thessaloniki; 2A’ Clinic of Internal Medicine, General Hospital Georgios Gennimatas, Thessaloniki, Greece

Citation Mironidou-Tzouveleki, M., Dokos, C., Andronoglou, M., Papadimouli, P., Kalousis, K.: Administration of antiplatelet agents in cardiovascular disorders: results from a clinical study, Epitheorese Klin. Farmakol. Farmakokinet. 22(2): 246-249 (2008)
Publication Date 23-25 May 2008
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)

pharmakonpress[at]pharmakonpress[.]gr

Keywords Antithrombotic drugs, platelet inhibitors, thrombosis, cardiovascular disorders, acute coronary syndrome, chronic heart failure, brain ischemic infraction.
Other Terms Review article
Summary Therapeutics of cardiovascular disorders remain an elite research area in modern pharmacology. With the evolution of molecular medicine, both pathophysiological and molecular background of cardiovascular disorders are examined thoroughly in order to identify novel pharmacological targets. Thrombus formation is a common event in cardiovascular disorders, such as acute coronary syndrome, chronic heart failure and brain ischemic infraction. In this study 19 patients, having one of the above diseases, were clinically examined and hospitalized under a specific therapeutic scheme. HDL, LDL, TG and PLT values were estimated in correlation with the drugs administrated. According to the results, platelets’ cyclooxygenase inhibitor (acetylsalycilic acid) and ADP-receptor antagonist (clopidogrel) are the most common drug used as thromboprophylaxis for acute coronary syndrome, chronic heart failure and brain ischemic infraction. HDL mean levels were decreased in all disease-groups, but only brain ischemic infraction patients have relatively elevated LDL mean values (128.375 ± 27.6). Patients with coronary heart disease had relatively high mean TG levels (147.66 ± 56.53), while PLT were ranging in normal values in all disease-groups. Antiplatelet agents are an important therapeutic class in these three cardiovascular diseases and, according to our study must be prescribed only to patients with normal PLT numbers.
References 1. Fuster V., Alexander R.W., O’ Rourke R.A.: Hurst’s the Heart. 10th Edition, McGraw-Hill, U.S., 2001

2. Ellsworth J.A., Oliver M.L.: Mosby’s 2007 Medical Drug Reference. Elsevier, Mosby, Philadelphia, 2007

3. ΕΟΦΕθνικό Συνταγολόγιο 2003, Αθήνα, 2003

4. Myronidou M., Kokkas B., Kouyoumtzis A., Gregoriadis N., Lourbopoulos A., Mylonas I., Papadopoulos P.C., Papadopoulos C.L., Mirtsou-Fidani V.: Losartan increases NO production from the bovine aortic wall that is stimulated by angiotensin II. Eur. J. Inflamm. 1(3): 113-117 (2003)

5. Parissis J., Kostakis G., Rigas A.: Endothelial dysfunction in chronic cardiac failure: pathophysiology, clinical significance and treatment. Heart Failure (Greek Edition) 1(2): 105-116 (2004)

6. Mironidou-Tzouveleki M., Andronoglou M., Dokos C., Kalousis K., Andronoglou D.: Biochemical profile of patients with brain ischemic infractions in the General Hospital G. Gennimatas, Thessaloniki. Aristotle University Medical Journal 34(Sup): 150 (2007)

7. Cohuet G., Struijker-Boudier H.: Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol. Ther. 111: 81-89 (2006)

8. Hadjitolios A.I., Roudolf G., Zafeiropoulos A., Savopoulos C.G.: Managing brain stroke incidence. Iatriko Vima (Greek Edition) 109: 12-22 (2007)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2008 – ANNUAL SUBSCRIPTION 2008
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

Bookmark the permalink.

Comments are closed.